What's keeping people from getting lung cancer screening
Examining Barriers to Lung Cancer Screening
This project looks at why eligible adults—especially people from minority or low-income groups—don't get recommended low-dose CT lung cancer screening.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-11252562 on NIH RePORTER |
What this research studies
You may be asked to share your screening history and thoughts about low-dose CT lung scans while researchers review clinic records to see who gets screened and who doesn't. They'll examine factors like long smoking history, other health problems, travel time to screening centers, direct and indirect costs, and fears about being diagnosed. The team will compare lung screening rates with other cancer screenings and look for differences by race, income, and location. Methods will probably include surveys or interviews with patients and analysis of healthcare and access data to pinpoint practical barriers.
Who could benefit from this research
Good fit: Ideal candidates are adults who meet lung cancer screening eligibility (age and smoking history) and especially those from minority, rural, or low-income communities who face access barriers.
Not a fit: People who do not meet lung cancer screening eligibility (for example, never-smokers or those outside the age criteria) are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, the work could lead to changes that make it easier for eligible people—particularly minorities and low-income patients—to access life‑saving lung cancer screening.
How similar studies have performed: Large trials have shown low-dose CT screening reduces lung cancer deaths, and prior research has documented barriers and persistent disparities, but uptake remains low and uneven.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Wain, Kris — Kaiser Foundation Research Institute
- Study coordinator: Wain, Kris
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.